Effects of prolonged use of injectable hormonal contraceptive on serum lipid profile
- PMID: 15695947
Effects of prolonged use of injectable hormonal contraceptive on serum lipid profile
Abstract
The current study was carried out to determine serum levels of total cholesterol, triacylglycerol (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) in human female volunteers taking injectable hormonal contraceptives. For this purpose, 200 (two hundred) subjects with age range of 20-35 years were selected. Out of them, 140 (one hundred and forty) were experimental subjects and 60 (sixty) were control. Women without hormonal contraceptive were selected as the subjects of control group. The experimental subjects were taking injectable hormonal contraceptive, DMPA (depo-medroxyprogesterone acetate) for 3-5 years uninterruptedly. The mean serum total cholesterol and mean serum triacylglycerol levels of the DMPA users were significantly (P<O.05 and P<0.01 respectively) elevated in comparison to that of the non-users. The mean serum HDL-cholesterol was decreased in subjects using DMPA in comparison to that of the control group. But the decrease was not significant (P>0.05). The mean serum LDL-cholesterol level of the subjects of DMPA users was significantly (P<0.05) elevated in comparison to that of the control.
Similar articles
-
A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.Horm Metab Res. 1992 Feb;24(2):85-9. doi: 10.1055/s-2007-1003262. Horm Metab Res. 1992. PMID: 1533383
-
Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.Contraception. 2009 Jan;79(1):35-40. doi: 10.1016/j.contraception.2008.07.024. Epub 2008 Oct 1. Contraception. 2009. PMID: 19041439
-
Effect of prolonged use of injectable hormonal contraceptives on blood pressure and body weight.Mymensingh Med J. 2004 Jan;13(1):30-2. Mymensingh Med J. 2004. PMID: 14747781 Clinical Trial.
-
Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.J Reprod Med. 1996 May;41(5 Suppl):401-6. J Reprod Med. 1996. PMID: 8725702 Review.
-
Depo Provera. Position paper on clinical use, effectiveness and side effects.Br J Fam Plann. 1999 Jul;25(2):69-76. Br J Fam Plann. 1999. PMID: 10454658 Review.
Cited by
-
Effect of injectable and oral contraceptives on serum lipids.Obstet Gynecol. 2009 Oct;114(4):786-794. doi: 10.1097/AOG.0b013e3181b76bea. Obstet Gynecol. 2009. PMID: 19888036 Free PMC article.
-
Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use.Am J Obstet Gynecol. 2009 Mar;200(3):329.e1-8. doi: 10.1016/j.ajog.2008.12.052. Am J Obstet Gynecol. 2009. PMID: 19254592 Free PMC article. Clinical Trial.
-
Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community.Int J Womens Health. 2014 Jun 3;6:597-603. doi: 10.2147/IJWH.S59852. eCollection 2014. Int J Womens Health. 2014. PMID: 24940082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous